Possible involvement of TGF-β/periostin in fibrosis of right atrial appendages in patients with atrial fibrillation

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6859-6869

  Wu, Han ^a   Xie, Jun ^a   Li, Guan Nan ^a   Chen, Qin Hua ^a   Li, Ran ^a   Zhang, Xin Lin ^a   Kang, Li Na ^a   Xu, Biao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Fibrosis; Periostin; Recurrence; Transforming growth factor

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN; POSTN PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ATRIAL FIBRILLATION; BIOPSY; CATHETER ABLATION; CHEMISTRY; FEMALE; FIBROSIS; HEART ATRIUM APPENDAGE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING;

ADULT; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BIOPSY; BLOTTING, WESTERN; CATHETER ABLATION; CELL ADHESION MOLECULES; COLLAGEN; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; UP-REGULATION;

EID: 84938614555     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Syed TM and Halperin JL. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges. Nat Clin Pract Cardiovasc Med 2007; 4: 428-435.
2. Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H and Sen L. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004; 109: 363-368.
3. Knackstedt C, Gramley F, Schimpf T, Mischke K, Zarse M, Plisiene J, Schmid M, Lorenzen J, Frechen D, Neef P, Hanrath P, Kelm M and Schauerte P. Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. Cardiovasc Pathol 2008; 17: 318-324.
4. Nakatani Y, Nishida K, Sakabe M, Kataoka N, Sakamoto T, Yamaguchi Y, Iwamoto J, Mizumaki K, Fujiki A and Inoue H. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction. J Am Coll Cardiol 2013; 61: 582-588.
5. Mael-Ainin M, Abed A, Conway SJ, Dussaule JC and Chatziantoniou C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol 2014; 25: 1724-1736.
6. Liu W, Zi M, Tsui H, Chowdhury SK, Zeef L, Meng QJ, Travis M, Prehar S, Berry A, Hanley NA, Neyses L, Xiao RP, Oceandy D, Ke Y, Solaro RJ, Cartwright EJ, Lei M and Wang X. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circ Heart Fail 2013; 6: 833-844.
7. Lorts A, Schwanekamp JA, Baudino TA, McNally EM and Molkentin JD. Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. Proc Natl Acad Sci U S A 2012; 109: 10978-10983.
8. Xiao H, Lei H, Qin S, Ma K and Wang X. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Clin Cardiol 2010; 33: 149-156.
9. Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C and Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway. Int J Cardiol 2010; 143: 405-413.
10. Rahmutula D, Marcus GM, Wilson EE, Ding CH, Xiao YY, Paquet AC, Barbeau R, Barczak AJ, Erle DJ and Olgin JE. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-1. Cardiovasc Res 2013; 99: 769-779.
11. Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, Segerer S and Cohen CD. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol 2011; 179: 1756-1767.
12. Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, Muller SJ and Fahy JV. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 2010; 107: 14170-14175.
13. Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH and Markwald RR. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 2007; 302: 256-266.
14. Corradi D. Atrial fibrillation from the pathologist's perspective. Cardiovasc Pathol 2014; 23: 71-84.
15. Corradi D, Callegari S, Gelsomino S, Lorusso R and Macchi E. Morphology and pathophysiology of target anatomical sites for ablation procedures in patients with atrial fibrillation: part II: pulmonary veins, caval veins, ganglionated plexi, and ligament of Marshall. Int J Cardiol 2013; 168: 1769-1778.
16. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P and Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 2014; 311: 498-506.
17. Neilan TG, Mongeon FP, Shah RV, Coelho-Filho O, Abbasi SA, Dodson JA, McMullan CJ, Heydari B, Michaud GF, John RM, Blankstein R, Jerosch-Herold M and Kwong RY. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging 2014; 7: 1-11.
18. Saint LL and Damiano RJ Jr. Surgical treatment of atrial fibrillation. Mo Med 2012; 109: 281-287.
19. Yue L, Xie J and Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011; 89: 744-753.
20. Dawson K, Wakili R, Ordog B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kaab S and Nattel S. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013; 127: 1466-1475, 1475e1461-1428.
21. Cao H, Li Q, Li M, Od R, Wu Z, Zhou Q, Cao B, Chen B, Chen Y and Wang D. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. Int J Cardiol 2013; 166: 702-708.
22. Manabe I, Shindo T and Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 2002; 91: 1103-1113.
23. Grammer JB, Bohm J, Dufour A, Benz M, Lange R and Bauernschmitt R. Atrial fibrosis in heart surgery patients Decreased collagen III/I ratio in postoperative atrial fibrillation. Basic Res Cardiol 2005; 100: 288-294.
24. Kim SS, Jackson-Boeters L, Darling MR, Rieder MJ and Hamilton DW. Nifedipine Induces Periostin Expression in Gingival Fibroblasts through TGF-beta. J Dent Res 2013; 92: 1022-1028.
25. Yamashita O, Yoshimura K, Nagasawa A, Ueda K, Morikage N, Ikeda Y and Hamano K. Periostin links mechanical strain to inflammation in abdominal aortic aneurysm. PLoS One 2013; 8: e79753.
26. Takanami I, Abiko T and Koizumi S. Expression of periostin in patients with non-small cell lung cancer: correlation with angiogenesis and lymphangiogenesis. Int J Biol Markers 2008; 23: 182-186.
27. Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, Shao Y, Ma W, Yang D and Zhang J. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol 2014; 63: 373-378.
28. Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, Kawashima K, Kaneda Y, Ogihara T and Sugimura K. Periostin as a novel factor responsible for ventricular dilation. Circulation 2004; 110: 1806-1813.
29. Stansfield WE, Andersen NM, Tang RH and Selzman CH. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg 2009; 88: 1916-1921.
30. Pohjolainen V, Rysa J, Napankangas J, Koobi P, Eraranta A, Ilves M, Serpi R, Porsti I and Ruskoaho H. Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency. Nephrol Dial Transplant 2012; 27: 115-122.
31. Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, Zhou Y and Wu LL. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res 2011; 91: 80-89.
32. Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M and Okamura T. Periostin and bone marrow fibrosis. Int J Hematol 2008; 88: 57-63.
33. Akkaya M, Higuchi K, Koopmann M, Burgon N, Erdogan E, Damal K, Kholmovski E, McGann C and Marrouche NF. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace 2013; 15: 1725-1732.
34. den Uijl DW, Delgado V, Bertini M, Tops LF, Trines SA, van de Veire NR, Zeppenfeld K, Schalij MJ and Bax JJ. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011; 97: 1847-1851.
35. Saito T, Tamura K, Uchida D, Togashi M, Nitta T and Sugisaki Y. Histopathological features of the resected left atrial appendage as predictors of recurrence after surgery for atrial fibrillation in valvular heart disease. Circ J 2007; 71: 70-78.
36. Wu CH, Hu YF, Chou CY, Lin YJ, Chang SL, Lo LW, Tuan TC, Li CH, Chao TF, Chung FP, Liao JN and Chen SA. Transforming growth factor-beta1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation. Heart Rhythm 2013; 10: 10-15.
37. Wang W, Liu L, Li Y, Hu SS, Song YH and Wang X. Does the expression of transforming growth factor beta-1: affect the outcome of the radiofrequency modified maze procedure in patients with rheumatic atrial fibrillation? Tex Heart Inst J 2012; 39: 17-23.
38. On YK, Jeon ES, Lee SY, Shin DH, Choi JO, Sung J, Kim JS, Sung K and Park P. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. J Thorac Cardiovasc Surg 2009; 137: 1515-1520.